Pharma Journalist 8962 posts 0 comments

Aerpio Pharmaceuticals announced the completion of patient dosing in the Company’s TIME-2b study, a Phase 2b clinical trial designed to assess the efficacy and safety of Aerpio’s lead…
Read More...

Zymeworks reported the achievement of a new development milestone in its collaboration with Eli Lilly and Company. In accordance with Zymeworks’ 2014 licensing and collaboration…
Read More...

Lipocine Inc. announced approximately eight-week top-line interim results from an ongoing sixteen-week Liver Fat Imaging study ("Liver Fat Study") with LPCN 1144. The Liver Fat Study is…
Read More...

Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse platform technology for antibody drug discovery, announced the expansion of its existing non-exclusive…
Read More...

SMi reports: Conference Chairman Roderick E. Hubbard from Vernalis personally invites you The 3rd Annual Drug Discovery Chemistry Conference, which is proudly sponsored by Selvita.…
Read More...

SMi’s Annual Pre-Filled Syringes East Coast conference aims to keep delegates on top of the evolving market trends and the dynamic PFS industry. Now in its 6th year SMI’s Pre-Filled…
Read More...

AIVITA Biomedical announced the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1B clinical trial investigating the…
Read More...

Nexus Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) approval of Busulfan Injection, the company's AP-rated therapeutic equivalent for Busulfex 60 mg/10…
Read More...

Luye Pharma has announced it has entered an agreement with AstraZeneca China, the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharma's Xuezhikang Capsules in…
Read More...

Phoenix Molecular Designs announced that it has entered into a collaboration with Roche to develop a diagnostic (CDx) in triple-negative breast cancer (TNBC). The Roche CDx identifies…
Read More...